Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, October 6, 2014

BioTime, Inc. and Subsidiaries to Raise $31 Million Through Sales of Common Shares

BioTime, Inc. today announced that it has agreed to sell up to an aggregate of 9,431,398 common shares, in a registered direct offering at an offering price of $3.12 per share. The price per share was the closing price of our common shares on the NYSE MKT on October 2, 2014, the date on which we and the investors agreed upon the purchase price.

http://ift.tt/ZojFgU

No comments:

Post a Comment

Popular Stem Cell Roundup Posts